文献速递腹部CT

口服CT对比剂:新进展与意义——来自AJR对比剂专题系列

Oral CT Contrast Agents: What's New and Why, From the AJR Special Series on Contrast Media.
PubMed 文献 · AJR Am J Roentgenol · 2023-10-25

本文综述口服CT对比剂在腹部盆腔成像中的应用现状与前景,指出阳性与中性口服对比剂在提高肠管和腹膜病变显示的同时可能降低某些征象的检出;随着多能量CT和光子计数探测器CT的发展,新型暗对比剂和高Z口服对比剂有望结合两类现有对比剂的优势,并实现同时给予的静脉与口服对比剂分离显示。

要点

  • 现有口服对比剂在提高肠管和腹膜病变显示的同时,可能降低同一扫描中其他征象的检出。
  • 多能量CT为新型口服对比剂提供机会,可改善解剖勾画与病变检出。
  • 高Z口服对比剂有望利用光子计数探测器CT区分同时给予的静脉与口服对比剂。

核心结论

  • 现有口服CT对比剂在许多临床场景中提高肠管和腹膜病变的显示和诊断信心,尤其适用于门诊和肿瘤性腹部盆腔成像。
  • 新型暗口服对比剂和高Z口服对比剂有望结合阳性与中性口服对比剂的优势,提供与人体组织、静脉碘对比剂及其他新型CT对比剂不同的CT表现。
  • 高Z口服对比剂将释放多能量CT尤其是光子计数探测器CT的潜能,用于区分同时给予的静脉与口服对比剂。

研究设计与样本

  • 本文为AJR对比剂专题系列的综述,检索范围与纳入文献原文未报告。

局限性

  • 本文为综述,原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Current CT oral contrast agents improve the conspicuity of and confidence in bowel and peritoneal findings in many clinical scenarios, particularly for outpatient and oncologic abdominopelvic imaging. Yet, existing positive and neutral oral contrast agents may diminish the detectability of certain radiologic findings, frequently in the same scans in which the oral contrast agent improves the detectability of other findings. With ongoing improvements in CT technology, particularly multienergy CT, opportunities are opening for new types of oral contrast agents to further improve anatomic delineation and disease detection using CT. The CT signal of new dark oral contrast agents and of new high-Z oral contrast agents promises to combine the strengths of both positive and neutral oral CT contrast agents by providing distinct CT appearances in comparison with bodily tissues, iodinated IV contrast agents, and other classes of new CT contrast agents. High-Z oral contrast agents will unlock previously inaccessible capabilities of multienergy CT, particularly photon-counting detector CT, for differentiating simultaneously administered IV and oral contrast agents; this technique will allow generation of rich 3D, intuitive, perfectly coregistered, high-resolution image sets with individual contrast agent "colors" that provide compelling clarity for intertwined intraabdominal anatomy and disease processes.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Heimer MM, Sun Y, Bonitatibus PJ, et al. Oral CT Contrast Agents: What's New and Why, From the AJR Special Series on Contrast Media. AJR Am J Roentgenol. 2023. PMID: 37877595. doi:10.2214/AJR.23.29970

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。